![Elizabeth Comen, MD](/news/sites/default/files/styles/hero/public/2024-06/1500x1000_elizabeth-comen-hero-crop.jpg?h=9e6c008f&itok=rN80padv)
Dr. Comen will continue research into the ways that the immune system and breast cancer growth may be related.
CREDIT: NYU LANGONE STAFF
Elizabeth Comen, MD, an internationally recognized breast cancer聽oncologist and women鈥檚 health specialist known for her pioneering contributions in the field, has joined the Breast Cancer Center聽at 看片神器 Health鈥檚 Perlmutter Cancer Center聽as an associate professor in the 聽in its . She comes to 看片神器 from Memorial Sloan Kettering Cancer Center.
An award-winning oncologist and bestselling author, Dr. Comen has focused her clinical and translational research on the relationship between the immune system and breast cancer growth, particularly in metastatic disease.
鈥淒r. Comen鈥檚 dedication to advancing breast cancer research and treatment aligns perfectly with our commitment to providing the highest quality of care and conducting innovative research to better understand and treat cancer,鈥 said Alec Kimmelman, MD, PhD, the Anita Steckler and Joseph Steckler Professor and Chair of Radiation Oncology and director of Perlmutter Cancer Center. 鈥淲e are thrilled to welcome her to our team.鈥
Dr. Comen is renowned for her reputation as an advocate for women鈥檚 health聽and wellness. Her recently published book, All in Her Head, unpacks the legacy behind pervasive gaps in women鈥檚 healthcare.
She has also appeared in many local, national, and international news outlets, speaking to the complexities of breast cancer care to the general public to increase awareness and understanding, as well as advocating for women鈥檚 health more broadly. As a result of her work, Dr. Comen has also collaborated with organizations that include the White House Initiative on Women鈥檚 Health Research and the Women鈥檚 Health Access Matters (WHAM) Collaborative to promote equity for women鈥檚 health.
鈥淚 am honored to contribute to Perlmutter Cancer Center鈥檚 mission of providing compassionate, cutting-edge care to people facing breast cancer,鈥 said Dr. Comen. 鈥淚 look forward to working alongside my esteemed colleagues to further our understanding of this disease and improve outcomes for patients.鈥
About Dr. Comen
Dr. Comen earned her medical degree from Harvard Medical School and completed her internship and residency at Mount Sinai Hospital. She did her fellowships in medical oncology and advanced breast medicine at Memorial Sloan Kettering Cancer Center, where she then held several faculty positions.
Dr. Comen, who specializes in internal medicine and is board-certified in medical oncology, is an active member of several professional organizations and societies, including the American Society of Clinical Oncology and the American Medical Women鈥檚 Association. She has received a Department of Defense Breakthrough Award for research on breast cancer tumor鈥搃nfiltrating leukocytes that harbor mutations in oncogenes. The award is given to investigators whose research has high potential to make breakthroughs in the field of breast cancer.
Media Inquiries
Ryan Dziuba
Media Relations Manager
Phone: 212-404-4131
Ryan.Dziuba@NYULangone.org